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Background: Obesity is a pervasive problem and a popular subject of academic assessment. The ability to take
advantage of existing data, such as administrative databases, to study obesity is appealing. The objective of our
study was to assess the validity of obesity coding in an administrative database and compare the association
between obesity and outcomes in an administrative database versus registry.
Methods: This study was conducted using a coronary catheterization registry and an administrative database
(Discharge Abstract Database (DAD)). A Body Mass Index (BMI) ≥30 kg/m2 within the registry defined obesity. In the
DAD obesity was defined by diagnosis codes E65 – E68 (ICD-10). The sensitivity, specificity, negative predictive
value (NPV) and positive predictive value (PPV) of an obesity diagnosis in the DAD was determined using obesity
diagnosis in the registry as the referent. The association between obesity and outcomes was assessed.
Results: The study population of 17380 subjects was largely male (68.8%) with a mean BMI of 27.0 kg/m2. Obesity
prevalence was lower in the DAD than registry (2.4% vs. 20.3%). A diagnosis of obesity in the DAD had a sensitivity
7.75%, specificity 98.98%, NPV 80.84% and PPV 65.94%. Obesity was associated with decreased risk of death or
re-hospitalization, though non-significantly within the DAD. Obesity was significantly associated with an increased
risk of cardiac procedure in both databases.
Conclusions: Overall, obesity was poorly coded in the DAD. However, when coded, it was coded accurately.
Administrative databases are not an optimal datasource for obesity prevalence and incidence surveillance but could
be used to define obese cohorts for follow-up.
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Obesity is a highly prevalent health concern. While it is
well established that many North Americans are obese,
[1] similar trends are now being seen worldwide, even in
countries such as India, where malnutrition was long the
most common nutritional disorder. Obesity is now in
line to overtake smoking as the leading preventable
cause of morbidity and mortality, causing in excess of
300,000 deaths per year in the United States alone [2,3].
The burden of disease attributable to obesity is in large* Correspondence: bmartin@ucalgary.ca
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reproduction in any medium, provided the orpart due to its impact on the cardiovascular system of
these individuals [4-6].
There are several published ways of measuring obes-
ity, ranging from the simple, such as body mass index
(BMI, kg/m2) or waist circumference, to the complex,
including body densitometry and more advanced volumet-
ric techniques such as computed tomography (CT) imaging
and magnetic resonance imaging (MRI) [7,8]. While the
latter methodologies offer more accurate measurements of
body composition, the former are more widely employed
due to their relatively low cost, ease of use and familiarity.
They are, however, prone to bias: frequently measures of
weight and height are taken based on self -report which is
rather unreliable, as women tend to underreport weight
and men to over report height.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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is difficult and time consuming: national surveys such as
NHANES are expensive, and international studies such
as the International Day for the Evaluation of Abdominal
Obesity (IDEA) are logistically challenging [9]. It is even
more challenging for follow-up studies to collect longi-
tudinal information on obesity and outcomes from a
large population. Being able to take advantage of existing
administrative data, such as physicians claim and hospital
discharge databases, could be potentially time and cost
saving because obesity is captured as a diagnosis by the
International Classification of Disease (ICD), codes 278
(ICD-9-CM) and E65 – E68 (ICD-10). In many developed
countries (such as Canada), there are massive national ad-
ministrative databases that are easily linked with other data-
bases for research purposes. However, even though BMI is
easily derived from standard clinical information, adminis-
trative data frequently does not capture height and weight.
There has only been limited evaluation of how frequently
obesity is actually captured in administrative databases,
or how accurately it is captured. A study by Quan et al
from 2003 assessed obesity coding as one of their outcomes
[10]. Chart review demonstrated an 8.3% frequency
of obesity – while ICD-9-CM data reflected a 2.7%
(sensitivity 24.6% and positive predictive value (PPV)
75.9%) rate of obesity, and ICD-10 coding a 1.9% rate
(sensitivity 18.6%, PPV83.8%). The association between
coded obesity and adverse outcomes has not been well
studied in administrative databases, such as those used
in Canadian health care systems.
The objective of our study was to assess the validity of
obesity coding in an administrative database. To conduct
this study, we linked clinically captured physical measure-
ment data, including height and weight, with administrative
data to asses how frequently and accurately obesity is cap-
tured in an administrative database. To understand per-
formance of obesity research using administrative data, we
then determined the association between obesity and out-
comes in an administrative database first and then replicate
such analysis in registry. We evaluated if results generated
from these two databases are comparable. This study will
enrich the available information on obesity coding, and will
allow the assessment of the utility of administrative data for
population surveillance of obesity.
Methods
Defining obesity in physical measurement dataset
Our study was conducted using two data sources: The
Alberta Provincial Project for Outcomes Assessment in
Coronary Heart Disease (APPROACH) database and the
Inpatient Discharge Abstract Database for the Calgary
health region.
APPROACH is a clinical registry which has captured
detailed clinical information on all patients undergoingcardiac catheterization in Alberta, Canada since 1995 [11].
At the time of catheterization, data are collected on clinical
risk factors including age, sex, weight, height, body mass
index (BMI, kg/m2), hypertension, hyperlipidemia, diabetes,
chronic lung disease, cerebrovascular disease, congestive
heart failure, peripheral vascular disease, renal disease, liver
or gastrointestinal disease, and malignancy. Also recorded
are the results of coronary catheterization including coron-
ary anatomy and left ventricular ejection fraction, proce-
dures done at the time of initial catheterization and events
thereafter (percutaneous coronary intervention (PCI),
coronary artery bypass grafting (CABG) and death).
Obesity was defined within the APPROACH database
using the Quetelet formula for BMI: weight (kilograms)
divided by height (m) squared. A subject was determined
to be obese in the APPROACH database if they had a
BMI ≥ 30 kg/m2. Obesity classes were determined using the
standard World Health Organization definitions: subjects
with a BMI 30-34.99 kg/m2 were considered Obesity
Class I, subjects with a BMI 35-39.99 kg/m2 were consid-
ered Obesity Class II, and subjects with a BMI ≥ 40 kg/m2
were considered Obesity Class III [12].
Defining obesity in the hospital discharge abstract database
The Inpatient Discharge Abstract Database (DAD) collects
administrative information on date and time of admission,
length of stay and up to 25 diagnoses. Using the DAD for
the years 2002-2008, obesity was defined by searching the
diagnosis codes E65 – E68 (ICD-10) in the 25 diagnosis
coding fields.
The APPROACH database and DAD were linked using
Personal Health Numbers (PHNs), which are unique to
each individual. Patients were excluded if they were under
18 years of age, did not have a valid Alberta PHN, or were
from outside the Calgary Health Region. As the clinical
covariates used for the study were obtained from the
APPROACH database, cohort entry date was defined as
the date of coronary catheterization. Only subjects who
had a hospitalization in the first 6 months following
catheterization were considered in this study. The diag-
nosis of obesity in the DAD was ascertained at the time
of first hospitalization following catheterization.
Outcomes variables
The outcomes of interest were all cause mortality, as cap-
tured by vital statistics, first hospitalization (any cause) and
first cardiac procedure (percutaneous coronary intervention
(PCI) and coronary artery bypass grafting (CABG)) in
the first year after the date of coronary catheterization.
For those patients with multiple admissions in the fol-
lowing year after coronary catheterization, only the
first admission was counted. The outcomes of PCI and
CABG were obtained from the APPROACH database,
and hospitalizations from the DAD.
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Descriptive statistics were used to describe study population
characteristics. Subjects were considered to be “correctly”
coded as obese if they had a diagnosis code of obesity in
the administrative database and a BMI ≥ 30 kg/m2 in the
measured data contained in APPROACH. The sensitivity,
specificity, negative predictive value (NPV) and positive
predictive value (PPV) of a diagnosis of obesity as coded
in the administrative databases were determined using the
physical measurement of obesity as the referent value.
Each of these validity indices was calculated over the
entire study time period as well as by year (2002 – 2008).
The accuracy of coding was then considered across various
demographic categories and clinical conditions.
As a second step, we assessed the relative impact of being
coded as obese on outcomes, namely hospitalization, PCI
or CABG, and mortality. We considered the association
between obesity and outcomes in those correctly diagnosed
as obese within the administrative data, those diagnosed as
obese within APPROACH only, and those diagnosed as
obese within APPROACH or the administrative database.
The association between outcomes and obesity were evalu-
ated in multivariate logistic regression models. The Odds
Ratio (OR) between the outcomes and obesity and their
95% confidential intervals (95%CI) were estimated in logis-
tic regression model while controlling for other factors.
Statistical analysis was conducted using SAS Version 9.0.
The study protocol was approved by the ethics review
board of the University of Calgary.
Results
A total of 17,380 subjects were included in the initial ana-
lysis. Baseline characteristics of these patients are outlined
in Table 1. The study population was largely male (56.4%)
and 48.6% were aged ≥65 years old. Most subjects
underwent coronary catheterization for urgent reasons,
including myocardial infarction and unstable angina. In
APPROACH, there were 3523 (20.3%) subjects with a
BMI ≥ 30 kg/m2 (mean BMI of 32.84 kg/m2). Of these,
83.4% were obesity Class I, 13.5% were obesity Class II,
and 3.1% were obesity Class III. In the DAD, 414 patients
were coded as being obese.
Rates of obesity remained stable year to year (see Table 2).
The sensitivity of a diagnosis of obesity in the DAD was
low at 7.75%. However, it was highly specific at 99.0%,
with Negative Predictive Value (NPV) of 80.8% and a PPV
of 65.9% (Table 2). There were minor variations in the
sensitivity of an obesity diagnosis, under 10% throughout
the study time period. There were no clear trends or
improvements in sensitivity over time. Specificity and
NPV were excellent throughout the study period, at over
98% and 80% respectively.
Of those 414 subjects coded as obese in the DAD, nearly
a third (141) were not actually obese when compared tomeasured data. These incorrectly coded subjects had a
mean BMI of 26.9 kg/m2 (SD 3.6), were older (mean age
63.7 ± 10.8 years vs 62.7 ± 11.0, p-value = 0.3), less likely to
be female (33.3% vs 55.3%, p < 0.0001), and more likely to
be diabetic (35.5 vs 44.3%, p = 0.0827) than those who
were correctly coded as obese in both administrative and
clinical data (n = 273).
We further analyzed our data to assess whether or not
demographic or clinical factors would influence the PPV
of a DAD diagnosis of obesity (Table 2). The prevalence of
obesity was higher in female subjects (28.3%) than male
(16.6%), and the PPV was commensurately higher. The
sensitivity of an administrative database obesity diagnosis
was also higher in women. There were no trends across
age groups, with the exception of a lower prevalence of
obesity and PPV in the elderly (age >75 years) age group.
The prevalence of obesity and the PPV was higher amongst
those subjects with conditions associated with excess body
mass: namely, diabetes and hypertension. This association
was strongest for those with diabetes: the prevalence of
obesity in patients with diabetes was 29.0%, versus 17.9%
in those without; similarly, the PPV of an obesity diagno-
sis in the administrative database was higher amongst
those with diabetes (70.8%) than those without (62.6%).
The PPV did not seem to be impacted by a diagnosis of
hyperlipidemia, congestive heart failure, or a history of
previous myocardial infarction.
We further assessed whether BMI influenced the
likelihood that a subject was coded as obese in the ad-
ministrative database. Of those coded as obese within
the administrative database, the large majority (72.9%) were
Class I obese; of those not coded as obese, 84.3% were Class
I obese, and 2.9% were Class III obese (Table 3). Thus, the
higher the BMI by measured data the more likely subjects
were to be coded as obesity in the administrative data.
As a final step, we wished to determine if obesity as
coded in DAD was differentially associated with outcomes
in comparison to obesity as determined by physical
measurement. Over the course of the study, there were
7547 hospital admissions, 10772 CABG and PCIs, and
703 deaths. In subjects who were obese by DAD, there
was no significant association between obesity and re-
hospitalization or mortality (Table 4). The same was
demonstrated for those “correctly” coded as obese.
Considering those subjects who were obese by physical
measurement only, obesity was associated with decreased
risk of mortality or re-hospitalization, but an increased
risk of repeat procedure. The same was seen for sub-
jects who were obese by physical measurement or ad-
ministrative data.
Discussion
We have confirmed the findings of previous investigators
that administrative data under-coded obesity as a diagnosis.
Table 1 Baseline characteristics of the study population from clinical registry data (APPROACH)













Total 17380 29.96 ± 4.14 3523 32.84 ± 2.96 414 31.38 ± 4.57
Age
<55 4341 27.24 950 32.93 ± 2.96 105 31.34 ± 4.30
55-65 4600 27.27 1009 32.79 ± 3.08 121 31.30 ± 4.93
65-75 4842 27.06 1023 32.75 ± 2.82 118 31.49 ± 4.80
> = 75 3597 26.11 541 32.94 ± 3.00 70 31.42 ± 4.00
Gender
Female 5424 27.28 1535 33.72 ± 3.33 198 32.79 ± 4.88
Male 11956 26.82 1988 32.16 ± 2.43 216 30.10 ± 3.86
Indication for coronary catheterization
Stable angina 4715 27.26 1015 32.75 ± 2.65 129 31.79 ± 3.35
Myocardial infarction 6883 26.86 1312 32.78 ± 3.05 163 31.32 ± 4.52
Unstable angina 3705 27.20 843 32.96 ± 3.08 91 30.50 ± 5.40
Other 2077 26.23 353 33.02 ± 3.15 31 32.64 ± 6.14
Diabetes
Not diabetic 13717 26.70 2461 32.70 ± 2.86 243 30.99 ± 4.34
Diabetic 3663 27.94 1062 33.16 ± 3.15 171 31.95 ± 4.85
Cerebrovascular disease
No history of CVD 16116 26.98 3258 32.84 ± 3.00 375 31.24 ± 4.53
History of CVD 1264 26.72 265 32.77 ± 2.48 39 32.75 ± 4.85
Congestive heart failure
Absent 3062 32.78 ± 2.87 356 31.38 ± 4.40
Present 461 33.22 ± 3.49 58 31.41 ± 5.58
Hypertension
Non-hypertensive 6215 26.38 974 32.64 119 31.48
Hypertensive 11165 27.29 2549 32.91 295 31.34
Hyperlipidemia
Hyperlipidemic 4820 26.32 855 32.90 ± 2.90 93 31.85 ± 5.01
Non-hyperlipidemic 12560 27.21 2668 32.82 ± 2.98 321 31.25 ± 4.44
Prior MI
No history of MI 13007 26.97 2664 32.84 ± 2.97 302 31.53 ± 4.40
Prior MI 4373 26.96 859 32.83 ± 2.92 112 31.00 ± 5.01
Abbreviations: SD Standard Deviation, Obesity BMI ≥30 kg/m2, Obesity Class II BMI ≥35 kg/m2, Obesity Class III BMI ≥ 40 kg/m2.
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tively accurately, as for other chronic conditions [10]. Ad-
ministratively captured obesity was more likely in patients
with higher classes of obesity or obesity-related complica-
tions. Interestingly, despite our suspicion that obesity cod-
ing would improve over time with increasing general
awareness of the relationship between obesity and disease
we found no evidence for this. These finding suggest that
administrative databases could not be used for obesity sur-
veillance due to under-reporting but could potentially beused to identify obesity for forming a cohort of obese sub-
jects for follow-up studies.
Despite the general poor capture of obesity in admin-
istrative databases, we did find a number of conditions
under which obesity is better captured. The PPV of an
obesity diagnosis is higher in women than in men, and
it is also higher in a number of conditions that are
known to be associated with obesity, namely diabetes
and hypertension. Additionally, in those cases in which
obesity is actually captured, it is captured with great
Table 2 Obesity prevalence and the validity of hospital discharge abstract (DAD) administrative health database
coding of (n = 17380)
Prevalence in clinical registry,
based on physical measure (n,%)
Prevalence in DAD,
coded as obese (n,%)
Sensitivity Specificity NPV PPV
(%, 95% CI)
Overall 3523 (20.27) 414 (2.38) 7.75 98.98 80.84 65.94 (61.38,70.51)
Year
2002 607 (20.72) 85 (2.90) 8.24 98.49 80.41 58.82 (48.36, 69.29)
2003 517 (19.12) 80 (2.96) 9.48 98.58 82.16 61.25 (50.57, 71.93)
2004 564 (21.32) 67 (2.53) 8.69 99.14 80.02 73.13 (62.52, 83.75)
2005 499 (20.24) 42 (1.70) 5.81 99.34 80.6 69.05 (55.07, 83.03)
2006 466 (19.58) 39 (1.64) 6.44 99.53 81.38 76.92 (63.70, 90.15)
2007 443 (20.18) 41 (1.87) 5.87 99.14 80.64 63.41 (48.67, 78.16)
2008 427 (20.71) 60 (2.91) 9.37 98.78 80.67 66.67 (54.74, 78.59)
Age
<55 950 (21.88) 105 (2.42) 7.58 99.03 79.27 68.57
55-65 1009 (21.93) 121 (2.63) 7.63 98.77 79.19 63.64
65-75 1023 (21.13) 118 (2.44) 8.02 99.06 80.08 69.49
> = 75 541 (15.04) 70 (1.95) 7.76 99.08 85.85 60.00
Gender
Female 1535 (28.30) 198 (3.65) 9.84 98.79 73.52 76.26
Male 1988 (16.63) 216 (1.81) 6.14 99.06 84.11 56.48
Indication for coronary
catheterization
Stable angina 1015 (21.53) 129 (2.74) 8.77 98.92 79.81 68.99
Myocardial infarction 1312 (19.06) 163 (2.37) 7.85 98.92 82.01 63.19
Unstable angina 843 (22.75) 91 (2.46) 6.88 98.85 78.28 63.74
Other 353 (17.00) 31 (1.49) 6.52 99.54 83.87 74.19
Diabetes
Not diabetic 2461 (17.94) 243 (1.77) 6.18 99.19 82.86 62.55
Diabetic 1062 (28.99) 171 (4.67) 11.39 98.08 73.05 70.76
Cerebrovascular disease
No history of CVD 3258 (20.22) 375 (2.33) 7.49 98.98 80.85 65.07
History of CVD 265 (20.97) 39 (3.09) 10.94 99.00 80.73 74.36
Congestive heart failure
Absent 3062 (20.35) 356 (2.37) 7.64 98.98 80.74 65.73
Present 461 (19.73) 58 (2.48) 8.46 98.99 81.48 67.24
Hypertension
Non-hypertensive 974 (15.67) 119 (1.91) 7.80 99.18 85.27 63.87
Hypertensive 2549 (22.83) 295 (2.64) 7.73 98.86 78.36 66.78
Hyperlipidemia
Hyperlipidemic 855 (17.74) 93 (1.93) 7.49 99.27 83.27 68.82
Non-hyperlipidemic 2668 (21.24) 321 (2.56) 7.83 98.87 79.91 65.11
Prior MI
No history of MI 2664 (20.48) 302 (2.32) 7.43 98.99 80.59 65.66
Prior MI 859 (19.64) 112 (2.56) 8.73 98.95 81.60 66.96
Abbreviations: NPV Negative Predictive Value, PPV Positive Predictive Value, CI Confidence Interval.
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Table 3 Obesity class amongst (1) those coded obese in the DAD administrative health database, and (2) those not
coded obese in the DAD administrative health database
Obese in DAD Coded as Obese in the DAD
and by physical measure
Obese by physical measure and not
coded obese in administrative data
Obese by
physical measure
Number Percent Number Percent Number Percent Number Percent
Total 414 100 273 100 3250 100 3523 100
Weight Class
BMI <30 141 34.06 0 0 0 0 0 0
I (BMI 30-34.99 kg/m2) 199 48.07 199 72.89 2740 84.31 2939 83.42
II (BMI 35-39.99 kg/m2) 60 14.49 60 21.98 416 12.8 476 13.51
III (BMI≥ 40 kg/m2) 14 3.38 14 5.13 94 2.89 108 3.07
Abbreviations: BMI Body Mass Index.
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study. However the obese subjects as captured by the
administrative database are more likely to be Class III
obese than those who are not captured, i.e. there is a
bias towards coding those with a higher BMI as obese,
missing those who are Class I obese. Thus, the admin-
istrative databases are capturing subjects who perhaps
already have complications from their obesity, as evi-
denced by the fact that the PPV of an obesity diagnosis
in the administrative database is higher in those with
obesity related complications such as diabetes. Cohorts
defined using administrative data may therefore show a
falsely high correlation between obesity and the develop-
ment of complications or poor outcomes, as the obese
subjects correctly identified in administrative databases
are potentially sicker than an average obese subject.
Some work has been done assessing the validity of
obesity coding in administrative data in previous studies.
In one chart based study by Quan et al, only weight loss,
coagulopathy and blood loss anemia were less validly
coded than obesity in administrative data. In Switzerland,
obesity was under-coded (prevalence 2.2% in 1999, 3.2%
in 2001 and 4.1% in 2003) compared with the prevalence
in chart ranging 6.6-7.3% but coding improved over years
(sensitivity 29.4% in 1999, 39.5% in 2001 and 51.5% in
2003; PPV 92.%, 81.1% and 91.7% in these years, re-
spectively) [13]. Reasons put forth for the poor capture
of obesity in administrative data include the fact that
obesity is not explicitly mentioned in either physician orTable 4 The impact of obesity on one-year outcomes
Comparison groups
Obese by DAD data only (non-obese n = 16966, obese n = 414)
Obese by physical measurement and DAD (non obese = 17107, obese n = 27
Obese by physical measurement only (non-obese n = 14130, obese 3250)
Obese by physical measurement or DAD (non-obese n = 13857, obese 3523)
Obesity classified by data source: hospital discharge abstract (DAD) administrative h
*Adjusted for sex, age group (by decade), and co-morbidity (0, 1-4, or ≥ 5 of chronic
congestive heart failure, dialysis, hypertension, hyperlipidemia, previous myocardialnursing notes, and also that coders may intentionally not
code diagnoses such as obesity owing to time constraints
when doing data abstraction. In the limited time for coding
each chart, coders are likely to ignore risk factors, focusing
on overt clinical conditions. Coding guidelines pay more
attention to conditions contributing to resource use and
the use of extra resources by obese subjects is a topic that
is only more recently understood [14]. In addition, physi-
cians may not explicitly mention obesity in the chart sum-
mary page which coders mainly rely on, as obesity is poorly
recognized as a disease. BMI was also not well-documented
although height and weight are available on most clinical
charts. The diagnosis of obesity is often made based on
clinician’s subjective observation, likely capturing higher
class obesity. If administrative database data abstractors
are coding height and weight in the chart, rates of obes-
ity are likely to be accurate.
Another difficulty in defining obesity is the use of patient
self-reported data. On patient admission to hospital, height
and weight are frequently determined by patient report,
and this information is then recorded in the patient record.
It has been shown that patients overestimate their height
and underestimate their weight, which leads to underesti-
mates of the prevalence of obesity. This misrepresentation
of BMI is more common in the obese [15].
A recent study by Woo et al [16] considered both
hospital administrative data and a clinical database that
captured height and weight for all children admitted to
hospital. The administrative database failed to captureOdds ratio (95%CI)*
Re-hospitalization CABG or PCI Mortality
0.84 (0.68, 1.03) 2.26 (1.77, 2.88) 0.74 (0.42, 1.32)
3) 0.90 (0.70, 1.15) 2.81 (2.07, 3.81) 0.60 (0.28, 1.30)
0.84 (0.78, 0.91) 1.20 (1.10, 1.31) 0.62 (0.49, 0.78)
0.83 (0.77, 0.90) 1.22 (1.12, 1.32) 0.63 (0.51, 0.79)
ealth database and clinical registry physical measurement (N = 17380).
obstructive pulmonary disease, cerebrovascular disease, renal disease,
infarction, peripheral vascular disease, and diabetes).
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ted to hospital. A diagnosis of obesity in the administrative
database only had an 8% sensitivity based on their BMI.
More importantly, when outcomes were compared be-
tween non-obese children and obese children based on
(a) obesity as captured in the administrative database
versus (b) obesity as captured in the clinical database, the
impact of obesity was found to be different. A diagnosis
of obesity recorded in the administrative data identified
“sporadic, potentially non-representative, hospital dis-
charges with shorter lengths of stay.” However our study
demonstrated that the association between obesity and
each of the outcomes (hospitalization, PCI/CABG or death)
were similar between regardless of how obesity was
coded. Differences arose in terms of the significance
(for mortality, likely due to the small number of deaths,
and for re-hospitalization), and in terms of the magnitude
for PCI/CABG.
For missing information on obesity in administrative
data, merging with clinical databases such as was done
in this study is an important way by which to enhance the
quality data found in administrative databases. Additionally,
physician claims databases as well as prescription databases
are potential sources of obesity information. In a re-
view of available literature, nearly all studies of obesity
using larger databases are not based on administrative
databases alone. This includes papers from NHANES
assessing obesity prevalence [17,18], studies assessing
the association between adiposity and cardiovascular
outcomes, [19-25] and studies assessing care in obese
subjects [26,27]. For instance, in a paper by Chang et al.,
while Medicare claims and enrollment were used to assess
for service utilization, data on BMI were obtained from
a merge with the Medicare Current Beneficiary Survey
(MCBS). Similar studies done strictly using administrative
or claims data without data enrichment to determine BMI
would only identify a high risk group of obese subjects [28].
Limitations
There are a number of limitations in this study that need be
noted. Firstly, we have only considered cardiac patients. As
cardiovascular disease is a complication related to obesity,
rates of obesity coding in administrative data may be higher
among this population than in the general inpatient popula-
tion. However, in a study by Quan et al assessing a random
sample of charts, obesity had prevalence 2.7% in ICD-9-
CM DAD and 1.9% in ICD-10 DAD [10] similar to the rate
seen in this population. We could also only consider the
impact of coding on outcomes in cardiac populations; more
distinct patient populations need to be assessed.
Conclusions
A call to arms has been put forth by organizations such as
the American Heart Association, recognizing that healthcare providers have not done a good job assessing for
obesity and suggesting “the measurement and documenta-
tion of BMI in all adults” [29,30]. In this study we have dem-
onstrated that even when obesity is present, care givers and
coders do a poor job documenting its presence – though
subjects at highest risk of complications are accurately
identified. This large study demonstrates three key pieces of
information: obesity is underreported in administrative data
with low sensitivity, and hence cannot be used for incidence
and prevalence surveillance; obesity coding in administra-
tive databases could be used to define a cohort for follow-
up or outcomes studies, supported by high PPV and similar
outcomes conclusions between two databases; finally, we
strongly recommend adding height and weight into routine
administrative data coding, as is done age and sex. This
would make these data an invaluable resource for studies of
obesity and population health.
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